Aspire Biopharma Holdings ASBP Ratios (2022-2026)

NASDAQ ASBP
$8.10 +0.28 (+3.64%)
As of: Aug 21, 2026 · 12:01 PM EDT
Ratios Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Profitability
Gross Margin (Quarter) 45.54%-23.47%20.28%-47.68%
EBT Margin (Quarter) -135,268.16%-189,692.96%-11,367.02%-2,009.61%
EBIT Margin (Quarter) -59,015.82%-43,403.52%-5,805.98%-4,244.14%
EBITDA Margin (Quarter) -59,015.82%-43,403.52%-5,805.98%-4,244.14%
Operating Margin (Quarter) -59,015.82%-43,403.52%-5,805.98%-4,244.14%
Net Margin (Quarter) -135,268.16%-189,692.96%-11,367.02%-2,009.61%
FCF Margin (Quarter) -56,868.06%-21,775.19%-10,716.76%-3,352.68%
Efficiency
Inventory Average (Quarter) 0.14M0.31M0.33M
Assets Average (Quarter) 148.40M296.61M297.28M299.01M301.64M161.84M20.23M19.94M20.09M13.53M1.06M1.48M1.70M1.86M4.21M10.33M
Invested Capital (Quarter) 0.01M0.22M0.43M4.90M3.62M0.50M0.50M4.74M1.29M0.50M
Asset Utilization Ratio (Quarter) 0.01
Leverage & Solvency
Interest Coverage Ratio (Quarter) -35.71
Debt Ratio (Quarter) 0.000.020.1227.590.250.501.972.130.07
Times Interest Earned (Quarter) -35.71
Valuation
Enterprise Value (Quarter) -12.17M
Return Ratios
Return on Sales (Quarter) -0.20%
Return on Capital Employed (Quarter) -84.69%
Return on Assets (Quarter) -0.01%